Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

NCT00118976 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type I
Diabetic Nephropathy

Interventions

DRUG: Lisinopril

Sponsor

Steno Diabetes Center Copenhagen